BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol 2009;471:305-33. [PMID: 19109787 DOI: 10.1007/978-1-59745-416-2_16] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Tang Q, Çağlayan M. The scaffold protein XRCC1 stabilizes the formation of polβ/gap DNA and ligase IIIα/nick DNA complexes in base excision repair. J Biol Chem 2021;297:101025. [PMID: 34339737 DOI: 10.1016/j.jbc.2021.101025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Peng Y, Pei H. DNA alkylation lesion repair: outcomes and implications in cancer chemotherapy. J Zhejiang Univ Sci B 2021;22:47-62. [PMID: 33448187 DOI: 10.1631/jzus.B2000344] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Meyer AV, Tolochko TA, Minina VI, Timofeeva AA, Larionov AV. Complex Approach to Evaluating Genotoxicity from Occupational Factors in Coal Mining Industry. Russ J Genet 2020;56:611-7. [DOI: 10.1134/s1022795420050105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Korgaonkar N, Yadav KS. Understanding the biology and advent of physics of cancer with perspicacity in current treatment therapy. Life Sciences 2019;239:117060. [DOI: 10.1016/j.lfs.2019.117060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
5 Lee KJ, Piett CG, Andrews JF, Mann E, Nagel ZD, Gassman NR. Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer. PLoS One 2019;14:e0223725. [PMID: 31596905 DOI: 10.1371/journal.pone.0223725] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
6 Lee KJ, Piett CG, Andrews JF, Mann E, Nagel ZD, Gassman NR. Defective base excision repair in the response to DNA damaging agents in triple negative breast cancer.. [DOI: 10.1101/685271] [Reference Citation Analysis]
7 Öztürk E, Pehlivan S, Balat O, Ugur MG, Ozcan HC, Erkılıç S. DNA Repair Gene (XPD, XRCC4, and XRCC1) Polymorphisms in Patients with Endometrial Hyperplasia: A Pilot Study. Med Sci Monit Basic Res 2018;24:146-50. [PMID: 30275440 DOI: 10.12659/MSMBR.911041] [Reference Citation Analysis]
8 Bashir K, Sarwar R, Saeed S, Mahjabeen I, Kayani MA. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma. PLoS One 2018;13:e0199007. [PMID: 30183716 DOI: 10.1371/journal.pone.0199007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
9 Nissar B, Kadla SA, Khan NS, Shah IA, Majid M, Afshan FU, Ganai BA. DNA Repair Gene XRCC1 and XPD Polymorphisms and Gastric Cancer Risk: A Case-Control Study Outcome from Kashmir, India. Anal Cell Pathol (Amst) 2018;2018:3806514. [PMID: 30225185 DOI: 10.1155/2018/3806514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Zhou X, Zeng Y, Jiang H, Xia L, Liu C. Predictive value of excision repair cross-complementing group 2 gene Lys751Gln and Asp312Asn polymorphisms in melanoma risk. Melanoma Res 2018;28:311-8. [PMID: 29768284 DOI: 10.1097/CMR.0000000000000463] [Reference Citation Analysis]
11 Azevedo AP, Silva SN, De Lima JP, Reichert A, Lima F, Júnior E, Rueff J. DNA repair genes polymorphisms and genetic susceptibility to Philadelphia-negative myeloproliferative neoplasms in a Portuguese population: The role of base excision repair genes polymorphisms. Oncol Lett 2017;13:4641-50. [PMID: 28599464 DOI: 10.3892/ol.2017.6065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Larionov AV, Sinitsky MY, Druzhinin VG, Volobaev VP, Minina VI, Asanov MA, Meyer AV, Tolochko TA, Kalyuzhnaya EE. DNA excision repair and double-strand break repair gene polymorphisms and the level of chromosome aberration in children with long-term exposure to radon. International Journal of Radiation Biology 2016;92:466-74. [DOI: 10.1080/09553002.2016.1186303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li X, Zhang G, Huai Y, Cao Z. Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis. Tumor Biol 2014;35:10111-9. [DOI: 10.1007/s13277-014-2115-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Qin Q, Lu J, Zhu H, Xu L, Cheng H, Zhan L, Yang X, Zhang C, Sun X. PARP-1 Val762Ala polymorphism and risk of cancer: a meta-analysis based on 39 case-control studies. PLoS One 2014;9:e98022. [PMID: 24853559 DOI: 10.1371/journal.pone.0098022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
15 Tummala H, Khalil HS, Zhelev N. Repair, Abort, Ignore? Strategies for Dealing With UV Damage. Biotechnology & Biotechnological Equipment 2014;25:2443-6. [DOI: 10.5504/bbeq.2011.0079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
16 Zhang X, Jiang LP, Yin Y, Wang YD. XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis. Tumour Biol 2014;35:5637-45. [PMID: 24590266 DOI: 10.1007/s13277-014-1746-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
17 Fenech MF. Nutriomes and Personalised Nutrition for DNA Damage Prevention, Telomere Integrity Maintenance and Cancer Growth Control. Advances in Nutrition and Cancer 2014. [DOI: 10.1007/978-3-642-38007-5_24] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
18 Tabrez S, Priyadarshini M, Priyamvada S, Khan MS, Na A, Zaidi SK. Gene–environment interactions in heavy metal and pesticide carcinogenesis. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2014;760:1-9. [DOI: 10.1016/j.mrgentox.2013.11.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
19 Du J, Lu C, Cui G, Chen Y, He J. DNA repair gene XRCC1 polymorphisms and susceptibility to childhood acute lymphoblastic leukemia: a meta-analysis. Chin J Cancer Res 2013;25:405-15. [PMID: 23997527 DOI: 10.3978/j.issn.1000-9604.2013.08.02] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Huang Y, Xie D, Tang N, Wang J, Zeng X, Zhao P, He L. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls. Tumour Biol 2014;35:799-808. [PMID: 23990457 DOI: 10.1007/s13277-013-1110-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
21 Alfadhli S, Nanda A. Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association. Clin Exp Med 2014;14:197-202. [PMID: 23584371 DOI: 10.1007/s10238-013-0228-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
22 Dong Y, Zhuang L, Ma W. Comprehensive assessment of the association of ERCC2 Lys751Gln polymorphism with susceptibility to cutaneous melanoma. Tumour Biol 2013;34:1155-60. [PMID: 23494240 DOI: 10.1007/s13277-013-0657-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Munshi A, Crotti LB, Sharma V, Sharma S, Espinoza LA. Pharmacogenomics of Allergy and Asthma. Omics for Personalized Medicine 2013. [DOI: 10.1007/978-81-322-1184-6_24] [Reference Citation Analysis]
24 Petkova R, Chelenkova P, Yemendzhiev H, Tsekov I, Chakarov S, Kalvatchev Z. HPV Has Left the Building—the Absence of Detectable HPV DNA and the Presence of R Allele/S for the P72R Polymorphism in the TP53 Gene May Call for More Aggressive Therapeutic Approach in HPV-Associated Tumours. Biotechnology & Biotechnological Equipment 2013;27:4217-21. [DOI: 10.5504/bbeq.2013.0104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
25 Przybylowska-Sygut K, Stanczyk M, Kusinska R, Kordek R, Majsterek I. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer 2013;13:61-8. [PMID: 23103366 DOI: 10.1016/j.clbc.2012.09.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
26 Xie T, Wang ZG, Zhang JL, Liu H. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 2012; 18(31): 4207-4214 [PMID: 22919255 DOI: 10.3748/wjg.v18.i31.4207] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
27 Roszak A, Lianeri M, Jagodzinski PP. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma. Int J Biol Markers 2011;26:216-20. [PMID: 21928248 DOI: 10.5301/JBM.2011.8581] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
28 Fu D, Calvo JA, Samson LD. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer 2012;12:104-20. [PMID: 22237395 DOI: 10.1038/nrc3185] [Cited by in Crossref: 586] [Cited by in F6Publishing: 619] [Article Influence: 53.3] [Reference Citation Analysis]
29 Khalil HS, Petkova R, Zhelev N. Differential Genetic Advantages in Youth and in Aging, or How to Die Healthy. Biotechnology & Biotechnological Equipment 2012;26:2703-2711. [DOI: 10.5504/bbeq.2011.0151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
30 Duman N, Aktan M, Ozturk S, Palanduz S, Cakiris A, Ustek D, Ozbek U, Nalcaci M, Cefle K. Investigation of Arg399Gln and Arg194Trp polymorphisms of the XRCC1 (x-ray cross-complementing group 1) gene and its correlation to sister chromatid exchange frequency in patients with chronic lymphocytic leukemia. Genet Test Mol Biomarkers 2012;16:287-91. [PMID: 22106831 DOI: 10.1089/gtmb.2011.0152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
31 McNeill DR, Lin PC, Miller MG, Pistell PJ, de Souza-Pinto NC, Fishbein KW, Spencer RG, Liu Y, Pettan-Brewer C, Ladiges WC, Wilson DM 3rd. XRCC1 haploinsufficiency in mice has little effect on aging, but adversely modifies exposure-dependent susceptibility. Nucleic Acids Res 2011;39:7992-8004. [PMID: 21737425 DOI: 10.1093/nar/gkr280] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
32 Qin HD, Shugart YY, Bei JX, Pan QH, Chen L, Feng QS, Chen LZ, Huang W, Liu JJ, Jorgensen TJ, Zeng YX, Jia WH. Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Res 2011;71:3000-8. [PMID: 21368091 DOI: 10.1158/0008-5472.CAN-10-0469] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
33 Ginsberg G, Guyton K, Johns D, Schimek J, Angle K, Sonawane B. Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment. Crit Rev Toxicol 2010;40:575-619. [PMID: 20662711 DOI: 10.3109/10408441003742895] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
34 Quan L, Stassen AP, Ruivenkamp CA, van Wezel T, Fijneman RJ, Hutson A, Kakarlapudi N, Hart AA, Demant P. Most lung and colon cancer susceptibility genes are pair-wise linked in mice, humans and rats. PLoS One 2011;6:e14727. [PMID: 21390212 DOI: 10.1371/journal.pone.0014727] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
35 Xue H, Ni P, Lin B, Xu H, Huang G. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. Am J Epidemiol 2011;173:363-75. [PMID: 21216841 DOI: 10.1093/aje/kwq378] [Cited by in Crossref: 47] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
36 Wilson DM, Kim D, Berquist BR, Sigurdson AJ. Variation in base excision repair capacity. Mutat Res. 2011;711:100-112. [PMID: 21167187 DOI: 10.1016/j.mrfmmm.2010.12.004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 6.5] [Reference Citation Analysis]
37 Fenech MF. Nutriomes and nutrient arrays - the key to personalised nutrition for DNA damage prevention and cancer growth control. Genome Integr 2010;1:11. [PMID: 20704708 DOI: 10.1186/2041-9414-1-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
38 Lin Y, Lan Y, Wan L, Huang C, Lin C, Hsueh K, Chen D, Lin T, Tsai F. The NBS1 Genetic Polymorphisms and the Risk of the Systemic Lupus Erythematosus in Taiwanese Patients. J Clin Immunol 2010;30:643-8. [DOI: 10.1007/s10875-010-9427-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
39 Haffty BG, Goyal S, Kulkarni D, Green C, Vazquez A, Schiff D, Moran MS, Yang Q, Ganesan S, Hirsfield KM. Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). Int J Radiat Oncol Biol Phys 2011;80:385-91. [PMID: 20646866 DOI: 10.1016/j.ijrobp.2010.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
40 Kirkland JB. Poly ADP-ribose polymerase-1 and health. Exp Biol Med (Maywood) 2010;235:561-8. [PMID: 20463295 DOI: 10.1258/ebm.2010.009280] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]